See every side of every news story
Published Atlanta, United StatesUpdated

Early feasibility study of Siegel 8Fr TAVI valve launches - Cardiovascular News

Summary by Cardiovascular News
MiRus Siegel TAVI MiRus has announced the launch of the US multicentre early feasibility study (EFS) of the Siegel 8Fr aortic transcatheter heart valve. The first two cases were successfully performed by Pradeep K Yadav and Vinod H Thourani both of Piedmont Heart Institute (Atlanta, USA). Both patients were discharged without complications the next day. The Siegel valve encompasses an 8Fr delivery sheath allowing less invasive procedures and bro…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cardiovascular News broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read 2 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.